606 related articles for article (PubMed ID: 29603900)
21. High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.
Cohen SE; Vittinghoff E; Bacon O; Doblecki-Lewis S; Postle BS; Feaster DJ; Matheson T; Trainor N; Blue RW; Estrada Y; Coleman ME; Elion R; Castro JG; Chege W; Philip SS; Buchbinder S; Kolber MA; Liu AY
J Acquir Immune Defic Syndr; 2015 Apr; 68(4):439-48. PubMed ID: 25501614
[TBL] [Abstract][Full Text] [Related]
22. HPTN 067/ADAPT: Correlates of Sex-Related Pre-exposure Prophylaxis Adherence, Thai Men Who Have Sex With Men, and Transgender Women, 2012-2013.
Holtz TH; Chitwarakorn A; Hughes JP; Curlin ME; Varangrat A; Li M; Amico KR; Mock PA; Grant RM;
J Acquir Immune Defic Syndr; 2019 Oct; 82(2):e18-e26. PubMed ID: 31490342
[TBL] [Abstract][Full Text] [Related]
23. Determinants of adherence to daily PrEP measured as intracellular tenofovir diphosphate concentrations over 24 months of follow-up among men who have sex with men.
van den Elshout MA; Hoornenborg E; Coyer L; Anderson PL; Davidovich U; de Vries HJ; Prins M; Schim van der Loeff MF;
Sex Transm Infect; 2023 Aug; 99(5):303-310. PubMed ID: 37258273
[TBL] [Abstract][Full Text] [Related]
24. Imperfect adherence in real life: a prevention-effective perspective on adherence to daily and event-driven HIV pre-exposure prophylaxis among men who have sex with men - a prospective cohort study in Taiwan.
Wu HJ; Wen-Wei Ku S; Chang HH; Li CW; Ko NY; Strong C
J Int AIDS Soc; 2021 May; 24(5):e25733. PubMed ID: 34018330
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men.
McManus H; Grulich AE; Amin J; Selvey C; Vickers T; Bavinton B; Zablotska I; Vaccher S; Jin F; Holden J; Price K; Yeung B; Cabrera Quichua G; Ogilvie E; McNulty A; Smith D; Guy R
JAMA Netw Open; 2020 Dec; 3(12):e2030806. PubMed ID: 33355675
[TBL] [Abstract][Full Text] [Related]
26. Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report.
Hoornenborg E; Prins M; Achterbergh RCA; Woittiez LR; Cornelissen M; Jurriaans S; Kootstra NA; Anderson PL; Reiss P; de Vries HJC; Prins JM; de Bree GJ;
Lancet HIV; 2017 Nov; 4(11):e522-e528. PubMed ID: 28919303
[TBL] [Abstract][Full Text] [Related]
27. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
[TBL] [Abstract][Full Text] [Related]
28. Pre-exposure prophylaxis initiation and adherence among Black men who have sex with men (MSM) in three US cities: results from the HPTN 073 study.
Wheeler DP; Fields SD; Beauchamp G; Chen YQ; Emel LM; Hightow-Weidman L; Hucks-Ortiz C; Kuo I; Lucas J; Magnus M; Mayer KH; Nelson LE; Hendrix CW; Piwowar-Manning E; Shoptaw S; Watkins P; Watson CC; Wilton L
J Int AIDS Soc; 2019 Feb; 22(2):e25223. PubMed ID: 30768776
[TBL] [Abstract][Full Text] [Related]
29. Comparison between daily and on-demand PrEP (pre-exposure prophylaxis) regimen in covering condomless anal intercourse for men who have sex with men in Hong Kong: A randomized, controlled, open-label, crossover trial.
Kwan TH; Lui GCY; Lam TTN; Lee KCK; Wong NS; Chan DPC; Lee SS
J Int AIDS Soc; 2021 Sep; 24(9):e25795. PubMed ID: 34473402
[TBL] [Abstract][Full Text] [Related]
30. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
[TBL] [Abstract][Full Text] [Related]
31. Change in sexual risk behaviour after 6 months of pre-exposure prophylaxis use: results from the Amsterdam pre-exposure prophylaxis demonstration project.
Hoornenborg E; Coyer L; van Laarhoven A; Achterbergh R; de Vries H; Prins M; van der Loeff MS;
AIDS; 2018 Jul; 32(11):1527-1532. PubMed ID: 29762169
[TBL] [Abstract][Full Text] [Related]
32. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
[TBL] [Abstract][Full Text] [Related]
33. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
[TBL] [Abstract][Full Text] [Related]
34. Preference for daily versus on-demand pre-exposure prophylaxis for HIV and correlates among men who have sex with men: the China Real-world Oral PrEP Demonstration study.
Zhang J; Xu JJ; Wang HY; Huang XJ; Chen YK; Wang H; Chu ZX; Hu QH; He XQ; Li Y; Zhang LK; Hu ZL; Bao RT; Li SC; Li H; Ding HB; Jiang YJ; Geng WQ; Sylvia S; Shang H;
J Int AIDS Soc; 2021 Feb; 24(2):e25667. PubMed ID: 33586841
[TBL] [Abstract][Full Text] [Related]
35. Same-Day Initiation of Oral Pre-Exposure Prophylaxis is High Among Adolescent Men Who Have Sex With Men and Transgender Women in Brazil.
Soares F; Magno L; Pinto JA; Grangeiro A; Bruxvoort K; Greco D; Dourado I
J Adolesc Health; 2023 Dec; 73(6S):S26-S32. PubMed ID: 37953005
[TBL] [Abstract][Full Text] [Related]
36. Pre-exposure prophylaxis in real life: experience from a prospective, observational and demonstration project among men who have sex with men in Benin, West Africa.
Diabaté S; Béhanzin L; Guédou FA; Goma-Matsétsé E; Olodo M; Aza-Gnandji M; Dossouvo A; Akpaka A; Chagas E; Gangbo F; Zannou DM; Alary M
J Int AIDS Soc; 2023 Jun; 26(6):e26130. PubMed ID: 37306106
[TBL] [Abstract][Full Text] [Related]
37. Trends in Sexual Behavior and Sexually Transmitted Infections After Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study.
Coyer L; Prins M; Davidovich U; van Bilsen WPH; Schim van der Loeff MF; Hoornenborg E; Matser A; Boyd A
AIDS Patient Care STDS; 2022 Jun; 36(6):208-218. PubMed ID: 35687814
[TBL] [Abstract][Full Text] [Related]
38. HPTN 083-02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study.
Psaros C; Goodman GR; Lee JS; Rice W; Kelley CF; Oyedele T; Coelho LE; Phanuphak N; Singh Y; Middelkoop K; Griffith S; McCauley M; Rooney J; Rinehart AR; Clark J; Go V; Sugarman J; Fields SD; Adeyeye A; Grinsztejn B; Landovitz RJ; Safren SA;
J Int AIDS Soc; 2024 May; 27(5):e26252. PubMed ID: 38783534
[TBL] [Abstract][Full Text] [Related]
39. Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study.
Grant RM; Mannheimer S; Hughes JP; Hirsch-Moverman Y; Loquere A; Chitwarakorn A; Curlin ME; Li M; Amico KR; Hendrix CW; Anderson PL; Dye BJ; Marzinke MA; Piwowar-Manning E; McKinstry L; Elharrar V; Stirratt M; Rooney JF; Eshleman SH; McNicholl JM; van Griensven F; Holtz TH
Clin Infect Dis; 2018 May; 66(11):1712-1721. PubMed ID: 29420695
[TBL] [Abstract][Full Text] [Related]
40. Skating on thin ice: stimulant use and sub-optimal adherence to HIV pre-exposure prophylaxis.
Hojilla JC; Vlahov D; Glidden DV; Amico KR; Mehrotra M; Hance R; Grant RM; Carrico AW
J Int AIDS Soc; 2018 Mar; 21(3):e25103. PubMed ID: 29577616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
